SCHEMBL444220

SCHEMBL444220

COC(=O)COCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.46
HSD17B10 Q99714 1/20 0.42
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
PTGS1 P23219 1/20 0.38
CTH P32929 1/20 0.38
CBS P35520 1/20 0.38
THPO P40225 1/20 0.38
THRB P10828 1/20 0.36
HSP90AB1 P08238 1/20 0.35
LMNA P02545 1/20 0.35
TET2 Q6N021 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
EGLN1 Q9GZT9 1/20 0.34
PAM P19021 2/20 0.34
VCAM1 P19320 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8255922 0.90 TSHR (0.43) TSHRHSD17B10MGAMGAASI
SCHEMBL1335833 0.89 TSHR (0.56) TSHRHSD17B10MGAMGAASI
SCHEMBL18856925 0.84 TSHR (0.39) TSHRHSD17B10MGAMGAASI
SCHEMBL14963628 0.84 TSHR (0.39) TSHRHSD17B10MGAMGAASI
Methoxymethane SCHEMBL3826793 0.83 TSHR (0.45) TSHRPTGS1CTHCBSTHPO
Ethylene Glycol SCHEMBL9359880 0.81 TSHR (0.48) TSHRHSD17B10MGAMGAASI
Ethylene Glycol SCHEMBL9359829 0.81 TSHR (0.48) TSHRHSD17B10MGAMGAASI
SCHEMBL30839706 0.80 PTGS1 (0.36) TSHRPTGS1CTHCBSTHPO
SCHEMBL26928 0.80
SCHEMBL11956800 0.79 TSHR (0.46) TSHRHSD17B10MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014730-A1 Anti-fungal formulation of triterpene and essential oil REGENTS OF THE UNIVERSITY OF MINNESOTA 2005-01-20 US claimed
US-20040097436-A1 Triterpenes having antibacterial activity REGENTS OF THE UNIVERSITY OF MINNESOTA 2004-05-20 US claimed
US-6689767-B2 TRITERPENE BACTERICIDES REGENTS OF THE UNIVERSITY OF MINNESOTA 2004-02-10 US claimed
EP-1322661-A1 TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2003-07-02 EP claimed
US-20020128210-A1 Triterpenes having human antifungal and antiyeast activity REGENTS OF THE UNIVERSITY OF MINNESOTA 2002-09-12 US claimed
US-20020119935-A1 Triterpenes having antibacterial activity REGENTS OF THE UNIVERSITY OF MINNESOTA 2002-08-29 US claimed
WO-2002026762-A1 TRITERPENES HAVING ANTIBACTERIAL ACTIVITY REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2002-04-04 WO claimed
WO-2002026761-A1 TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2002-04-04 WO claimed
CN-122055355-A Compounds for the treatment of diabetes and related disorders 奥克兰联合服务有限公司 2026-05-15 CN disclosed
CN-120004727-A Fusel oil treatment method 中国石油化工股份有限公司 2025-05-16 CN disclosed
CN-120001378-A Catalyst and recovery method of glycollate oligomer fusel oil 中国石油化工股份有限公司 2025-05-16 CN disclosed
WO-2025042293-A1 COMPOUNDS FOR TREATING DIABETES AND RELATED CONDITIONS AUCKLAND UNISERVICES LIMITED (NZ) 2025-02-27 WO disclosed
CN-118541342-A Method of 庄信万丰股份有限公司 2024-08-23 CN disclosed
CN-118162134-A Catalyst for preparing methyl glycine and glycine from methyl glycolate, and preparation method and application thereof 陕西延长石油(集团)有限责任公司 2024-06-11 CN disclosed
US-20020128210-A1 Triterpenes having human antifungal and antiyeast activity REGENTS OF THE UNIVERSITY OF MINNESOTA 2002-09-12 US disclosed
US-20020119935-A1 Triterpenes having antibacterial activity REGENTS OF THE UNIVERSITY OF MINNESOTA 2002-08-29 US disclosed
WO-2002026762-A1 TRITERPENES HAVING ANTIBACTERIAL ACTIVITY REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2002-04-04 WO disclosed
WO-2002026761-A1 TRITERPENES HAVING FUNGICIDAL ACTIVITY AGAINST YEAST REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2002-04-04 WO disclosed
WO-2001036003-A2 SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES DRUG INNOVATION & DESIGN, INC. (US) 2001-05-25 WO disclosed
US-6221143-B1 FOR AQUEOUS OR SOLVENT BASED INK JET INKS CABOT CORPORATION 2001-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128210-A1 Triterpenes having human antifungal and antiyeast activity ERG28, LSS, MANBA TSHR 4070/4885HSD17B10 634/4885MGAM 54/4885
US-20050014730-A1 Anti-fungal formulation of triterpene and essential oil BET1, VRK1, VRK2 TSHR 3878/4885HSD17B10 2583/4885MGAM 2426/4885
US-20040097436-A1 Triterpenes having antibacterial activity BET1, PGGT1B, LSS TSHR 3699/4885HSD17B10 936/4885MGAM 310/4885
US-20020119935-A1 Triterpenes having antibacterial activity BET1, PGGT1B, LSS TSHR 3699/4885HSD17B10 936/4885MGAM 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.